What is Achieve Life Sciences?
Achieve Life Sciences is a specialty pharmaceutical company dedicated to combating the worldwide epidemic of smoking-related health issues and nicotine addiction. The company's core focus is on the development and commercialization of cytisinicline, a promising therapeutic agent aimed at aiding smoking cessation. This strategic financing positions Achieve Life Sciences to advance its pipeline and potentially bring its innovative solutions to a market in critical need of effective treatments.
How much funding has Achieve Life Sciences raised?
Achieve Life Sciences has raised a total of $85M across 2 funding rounds:
Debt
$25M
Other Financing Round
$60M
Debt (2021): $25M with participation from Silicon Valley Bank
Other Financing Round (2024): $60M led by Nantahala Capital Management, Sopharma, and Propel Bio Partners
Key Investors in Achieve Life Sciences
Silicon Valley Bank
Silicon Valley Bank is a financial institution offering a range of banking and financial services, often supporting technology and life science companies through various stages of growth.
Nantahala Capital Management
Nantahala Capital Management is a fundamentally-driven alternative investment firm specializing in micro-cap stocks, suggesting a focus on identifying undervalued companies with long-term growth potential.
Sopharma
Sopharma is a prominent Bulgarian pharmaceutical manufacturer with a broad portfolio of medicines, indicating a strategic interest in therapeutic development and commercialization within the healthcare industry.
What's next for Achieve Life Sciences?
The substantial enterprise-level financing, particularly the recent strategic investment, indicates a pivotal growth phase for Achieve Life Sciences. This capital infusion is expected to accelerate the company's research and development efforts, support clinical trial progression, and bolster its commercialization strategy for cytisinicline. The backing from sophisticated investors suggests confidence in the company's scientific approach and market potential, paving the way for significant advancements in the pharmaceutical sector focused on addiction therapies.
See full Achieve Life Sciences company page
